Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcella Tazzari

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Experimental & Clinical Cancer Research : CR|May 23, 2026
Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanomaMarcella Tazzari, Silvia Carloni, Jenny Bulgarelli, et al.
Journal of Translational Medicine|April 18, 2025
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trialJenny Bulgarelli, Claudia Piccinini, Emanuela Scarpi, et al.
Frontiers in Immunology|August 28, 2024
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)Laura Ridolfi, Lorena Gurrieri, Nada Riva, et al.
Journal of Translational Medicine|May 19, 2025
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalabilityIlaria Pisani, Giusi Melita, Patricia Borges de Souza, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Experimental & Clinical Cancer Research : CR|May 23, 2026
Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanomaMarcella Tazzari, Silvia Carloni, Jenny Bulgarelli, et al.
Journal of Translational Medicine|April 18, 2025
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trialJenny Bulgarelli, Claudia Piccinini, Emanuela Scarpi, et al.
Frontiers in Immunology|August 28, 2024
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)Laura Ridolfi, Lorena Gurrieri, Nada Riva, et al.
Journal of Translational Medicine|May 19, 2025
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalabilityIlaria Pisani, Giusi Melita, Patricia Borges de Souza, et al.
Pageof 4